Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules where a protected pyrrolidine ring is required, especially in peptide-based drugs. The Cbz-protected amine allows for selective deprotection and further functionalization during multi-step syntheses. Commonly employed in medicinal chemistry for building blocks in drug discovery programs targeting viral infections and metabolic disorders.